Adjuvant therapy for gastric adenocarcinoma with the apoptosis-inducing human monoclonal antibody SC-1: First clinical and histopathological results

Oncology Reports

Volumn 5, Issue 3, 1998, Pages 549-552

  Vollmers, H Peter ^a   Zimmermann, Ulrich ^c   Krenn, Veit ^a   Timmermann, Wolfgang ^b   Illert, Bertram ^b   Hensel, Frank ^a   Hermann, Ralph ^a   Thiede, Arnulf ^b   Wilhelm, Martin ^d   Rückle Lanz, Heide ^d   Reindl, Leopold ^e   Müller Hermelink, Hans Konrad ^a  

^a Institut fur Pathologie   (Germany)

^b UNIVERSITY HOSPITAL WÜRZBURG   (Germany)

^c Biozentrum   (Germany)

^d Medizinische Poliklinik   (Germany)

^e Missionsarztliche Klinik   (Germany)

Author keywords

Adjuvant therapy; Human monoclonal antibody SC 1; Specific apoptosis; Stomach cancer

Indexed keywords

MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY SC 1; UNCLASSIFIED DRUG;

ADULT; AGED; ANTIBODY PRODUCTION; APOPTOSIS; ARTICLE; CANCER ADJUVANT THERAPY; CANCER IMMUNOTHERAPY; CANCER REGRESSION; CELL IMMORTALIZATION; CLINICAL ARTICLE; CLINICAL TRIAL; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; HYBRIDOMA; MALE; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; STOMACH ADENOCARCINOMA; STOMACH BIOPSY;

EID: 13144266758     PISSN: 1021335X     EISSN: None     Source Type: Journal    
DOI: 10.3892/or.5.3.549     Document Type: Article

References (20)

1. Whelan SL, Parkin DM and MasuyerE (eds): Trends in cancer incidence and mortality. IACR Scientific Publications 102, Lyon, 1993.
2. Sipponen P: Helicobacter pylori infection: a common worldwide environmental risk factor for gastric cancer Endoscopy 24: 424-427, 1992.
3. Vollmers HP, Dämmrich J, Ribbert H, et al: Human monoclonal antibodies from stomach carcinoma patients react with Helicobacter pylori and stimulate stomach cancer cells in vitro, Cancer 74: 1525-1532, 1994.
4. Vollmers HP, O'Connor R, Müller J, Kirchner T, Müller-Hermelink HK: SC-1, a functional human monoclonal antibody against autologous stomach carcinoma cells. Cancer Res 49: 2471-2476, 1989.
5. Vollmers HP, Dämmrich J, Hensel F, et al: Differential expression of apoptosis receptors on diffuse and intestinal type stomach carcinoma. Cancer 79: 433-440, 1997.
6. Vollmers HP, Dämmrich J, Ribbert H, Wozniak E and Müller-Hermelink HK: Apoptosis of stomach carcinoma cells induced by a human monoclonal antibody. Cancer 76: 550-558, 1995.
7. Vollmers HP, Hensel F, Hermann R, et al: Tumor-specific apoptosis induced by the human monoclonal antibody SC-1: a new therapeutical approach for stomach cancer. Oncol Rep 5: 35-40, 1998.
8. Bach JF, Fracchia GN and Chatenoud L: Safety and efficacy of therapeutic monoclonal antibodies in clinical therapy. Immunol Today 14: 379-392, 1993.
9. Lees G and Darling A: Biosafety considerations. In: Monoclonal Antibodies: Principles and Applications. Birch JR and Lennox ES (eds). Wiley-Liss, New York, 1995.
10. Lauren P: The two histological main types of gastric carcinoma: diffuse and so-called intestinal type. APMIS 64: 31-49, 1965.
11. Kerr JFR, Winterford CM and Harmon BV: Apoptosis. Its significance in cancer and cancer therapy. Cancer 73: 2013-2026, 1994.
12. Chang AE and Shu S: Current status of adoptive immuno-therapy of cancer. Crit Rev Oncol Hematol 22: 213-228, 1996.
13. Nishinaka Y, Ravindranath MH and Irie FT: Development of human monoclonal antibody to ganglioside GM2 with potential for cancer treatment. Cancer Res 56: 5666-5671, 1996.
14. Isaacs JD, Wing MG, Greenwood JD, Hazleman BL, Hale G and Waldmann H: A therapeutic human IgG4 monoclonal antibody that depletes target cells in humans. Clin Exp Immunol 106: 427-433, 1996.
15. DeJager R, Abdel-Nabi H, Serafini A, Pecking A, Klein JL and Hanna MG Jr: Current status of cancer immunodetection with radiolabeled human monoclonal antibodies. Semin Nucl Med 2: 165-179, 1993.
16. Vollmers HP, Landenberg P, Dämmrich J, et al: Electro-immortalization of B-lymphocytes isolated from stomach carcinoma biopsy material. Hybridoma 12: 221-225, 1993.
17. Faller G, Vollmers HP, Weiglein I, et al: HAB-1, a new heteromyeloma for continuous production of human monoclonal antibodies. Br J Cancer 62: 595-598, 1990.
18. Vollmers HP and Birchmeier W: Monoclonal antibodies inhibit the adhesion of mouse B16 melanoma cells in vitro and block lung metastases in vivo. Proc Natl Acad Sci USA 80: 3729-3733, 1983.
19. Vollmers HP, Imhof B, Wieland I and Birchmeier W: Monoclonal antibodies NORM-1 and NORM-2 induce more normal behaviour in tumor cells in vitro and in vivo. Cell 40: 547-557, 1985.
20. Vollmers HP and Birchmeier W: Cell adhesion and metastasis: a monoclonal antibody approach. Trends Biochem Sci 8: 452-455, 1983.